Angptl4 ASO did not cause remarkable alterations in nondiabetic control mice, but caused significant reduction in fibrosis, collagen deposition, and glomerulosclerosis in diabetic mice, demonstrating that Angptl4 ASO improves the kidney phenotype (Fig. 7H). Here, ANGPTL4 is linked to glomerulosclerosis.